All In Biotech

Drug Trial Radar · NCT00560209

Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Study of ONO-1101 in Patients Scheduled for Coronary Angiography, a Double-Blind, Randomized,Placebo-Controlled, Parallel Group, Multi-Center Study

Last checked: Nov 21, 2026Latest source record: Jun 13, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 183 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

183

Actual

Start

Nov 2007

Primary completion

Nov 2008

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Nov 19, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Diagnostic
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for coronary angiography, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.

Conditions

  • Coronary Artery Disease

Interventions

  • ONO-1101Drug

    placebo for 1 minute IV

  • ONO-1101Drug

    0.06 mg/kg for 1 minute IV

  • ONO-1101Drug

    0.125 mg/kg for 1 minute IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CT image qualityTime frame: one day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kinki Region

    Kinki, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.